Site içinde arama yapın

bir ses eklendi Other

2025-09-09 14:13:41 -

Denosumab Market Evolution – From Trends to Transformation (2025–2031)

The Global Denosumab Market is expanding steadily as the demand for effective treatments for osteoporosis, bone loss associated with cancer, and other skeletal disorders rises worldwide. Denosumab is a monoclonal antibody drug that works by inhibiting RANKL (Receptor Activator of Nuclear factor Kappa-Β Ligand), a protein involved in bone resorption. By blocking this pathway,...

0 Yorumlar 0 hisse senetleri 49 Views 0 önizleme